PLUS1
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Outlook Therapeutics, Inc. (MM) | OTLK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.02 | 2.06 | 1.99 | 2.02 | 2.02 | 11:00:22 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 2.01 | 2.04 | 0.03 | 1.47% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 191 | 56,770 | $ 2.01 | $ 113,909 | 1,056,376 | 0.85 - 20.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:02:58 | 2 | $ 2.02 | USD |
Outlook Therapeutics, Inc. (MM) Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 44.64M | 22.10M | $ -30.09M | -10.26 | -1.48 | 13.84M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Outlook Therapeutics, Inc. (MM) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 7/01/2019 | 17:18 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 7/01/2019 | 17:06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 6/28/2019 | 17:16 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 6/27/2019 | 06:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) |
| 6/19/2019 | 18:19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 6/19/2019 | 17:30 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) |
| 6/14/2019 | 17:25 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OTLK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.15 | 2.23 | 1.99 | 2.0834 | 173k | -0.13 | -6.05% |
| 1 Month | 2.07 | 2.36 | 1.93 | 2.1206 | 334k | -0.05 | -2.42% |
| 3 Months | 1.55 | 4.08 | 0.85 | 2.3175 | 5M | 0.47 | 30.32% |
| 6 Months | 5.4416 | 20 | 0.85 | 2.5907 | 3M | -3.4216 | -62.88% |
| 1 Year | 5.6 | 20 | 0.85 | 2.6005 | 2M | -3.58 | -63.93% |
| 3 Years | 5.6 | 20 | 0.85 | 2.6005 | 2M | -3.58 | -63.93% |
| 5 Years | 5.6 | 20 | 0.85 | 2.6005 | 2M | -3.58 | -63.93% |
Outlook Therapeutics, Inc. (MM) Description
| Oncobiologics Inc is a clinical-stage biopharmaceutical company. It is engaged in identifying, developing, manufacturing and commercializing complex biosimilar therapeutics in the disease areas of immunology and oncology. |
